222 related articles for article (PubMed ID: 7191289)
61. Inherited AT-III deficiency: fast and slow inactivation of thrombin and factor Xa.
Mortensen JZ
Thromb Res; 1984 Mar; 33(5):511-5. PubMed ID: 6719397
[TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.
Bendetowicz AV; Béguin S; Caplain H; Hemker HC
Thromb Haemost; 1994 Mar; 71(3):305-13. PubMed ID: 8029794
[TBL] [Abstract][Full Text] [Related]
63. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
64. Coagulant versus amidolytic properties of human and bovine thrombins: implications in standardization and diagnostic usage.
Fareed J; Walenga JM; Svendsen LG; Bermes EW
Semin Thromb Hemost; 1986 Oct; 12(4):310-7. PubMed ID: 3787268
[TBL] [Abstract][Full Text] [Related]
65. The measurement of heparin. A method based on the potentiation of anti-factor Xa.
Denson KW; Bonnar J
Thromb Diath Haemorrh; 1973 Dec; 30(3):471-9. PubMed ID: 4787668
[No Abstract] [Full Text] [Related]
66. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
Odegård OR; Lie M
Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
[No Abstract] [Full Text] [Related]
67. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
[TBL] [Abstract][Full Text] [Related]
68. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
69. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.
Bernat A; Hoffmann P; Herbert JM
Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of low molecular weight heparin by protamine chloride in vivo.
Harenberg J; Gnasso A; de Vries JX; Zimmermann R; Augustin J
Thromb Res; 1985 Apr; 38(1):11-20. PubMed ID: 4002198
[TBL] [Abstract][Full Text] [Related]
71. Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.
ten Cate H; Lamping RJ; Henny CP; Prins A; ten Cate JW
Clin Chem; 1984 Jun; 30(6):860-4. PubMed ID: 6723041
[TBL] [Abstract][Full Text] [Related]
72. Properties of heparin--poly(methyl methacrylate) copolymers. II.
Labarre D; Jozefowicz M; Boffa MC
J Biomed Mater Res; 1977 Mar; 11(2):283-95. PubMed ID: 853045
[TBL] [Abstract][Full Text] [Related]
73. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
Poon MC; Hurst RE; Rives MS
Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
[TBL] [Abstract][Full Text] [Related]
74. Endogenous anticoagulation during extracorporeal perfusion: generation of a heparinlike inhibitor.
Murphy TL; Walker FJ; Taylor FB; Beller-Todd B; Archer LT; Sofer SS; Hinshaw LB
Am J Physiol; 1980 Dec; 239(6):H742-50. PubMed ID: 7446747
[TBL] [Abstract][Full Text] [Related]
75. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
Nordenman B; Nordling K; Björk I
Thromb Res; 1980 Feb 1-15; 17(3-4):595-600. PubMed ID: 7368180
[No Abstract] [Full Text] [Related]
76. On the molecular-weight-dependence of the anticoagulant activity of heparin.
Thunberg L; Lindahl U; Tengblad A; Laurent TC; Jackson CM
Biochem J; 1979 Jul; 181(1):241-43. PubMed ID: 486155
[TBL] [Abstract][Full Text] [Related]
77. Heparin.
Thomas DP
Clin Haematol; 1981 Jun; 10(2):443-58. PubMed ID: 7032783
[No Abstract] [Full Text] [Related]
78. Factor Xa inactivation by a heparinized hydrogel.
Rollason G; Sefton MV
Thromb Res; 1986 Nov; 44(4):517-25. PubMed ID: 3798412
[TBL] [Abstract][Full Text] [Related]
79. A novel semi-synthetic sulphated polysaccharide with potent antithrombin activity.
Nilsson IM; Rothman U; Stenberg P; Frohm B; Persson NH
Br J Haematol; 1982 Feb; 50(2):335-43. PubMed ID: 7059522
[TBL] [Abstract][Full Text] [Related]
80. In vitro evaluation of heparin fractions: old vs. new methods.
Walenga JM; Fareed J; Hoppensteadt D; Emanuele RM
Crit Rev Clin Lab Sci; 1986; 22(4):361-89. PubMed ID: 2936571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
